All In Biotech

Drug Trial Radar · NCT07730281

PRA-216 COPD Safety and Biomarker Study

A Phase 2 Randomized, Double-blind, Placebo-Controlled, Parallel-Group, Multi-Center Study to Evaluate the Safety and Efficacy of PRA-216 in Participants With Chronic Obstructive Pulmonary Disease (COPD) With Type 2 Inflammation

Last checked: Nov 19, 2026Latest source record: Oct 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

40

Planned (sponsor's estimate)

Start

Aug 25, 2026

Primary completion

Jun 1, 2027

Study completion Sep 1, 2027

Sponsor

Lead sponsor
Prana Therapies IncIndustry
Sponsor type
Industry
First posted
Jul 28, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 40 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will evaluate the safety, tolerability, pharmacokinetics and immunogenicity of PRA-216 compared to placebo in patients with chronic obstructive pulmonary disease (COPD).

Conditions

  • Chronic Obstructive Pulmonary Disease (COPD)

Interventions

  • PRA-216Drug

    biologic

  • PlaceboDrug

    matching placebo for PRA-216

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence, nature, and severity of treatment emergent adverse events (TEAEs) and serious adverse events (SAEs)Time frame: 40 weeks

Locations

5 sites in 1 country. Site status is shown where the registry gives one.

  • Emeritus Research Sydney

    Botany, New South Wales, Australia · Recruiting

  • Campbelltown Hospital

    Campbelltown, New South Wales, Australia · Not yet recruiting

  • University of the Sunshine Coast

    Birtinya, Queensland, Australia · Recruiting

  • Griffith University

    Southport, Queensland, Australia · Recruiting

  • Emeritus Research Camberwell

    Camberwell, Victoria, Australia · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.